HIGHLIGHTS
- who: Vamika Karn from the (UNIVERSITY) have published the research work: CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope, in the Journal: (JOURNAL)
SUMMARY
Breast cancer (BC) is the most common cause of cancer-related death and also a second leading etiology of mortality among women. CRISPR/Cas9: the background CRISPR/Cas system is a phenomenal gene-editing tool and referred as genetic scissors. It has been reported that mutations may occur in both catalytic domains (D10A for RuvC and H840A for HNH in S. pyogenes Cas9) and results . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.